Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?
Yıl: 2022 Cilt: 27 Sayı: 4 Sayfa Aralığı: 627 - 633 Metin Dili: İngilizce DOI: 10.5505/ejm.2022.45549 İndeks Tarihi: 26-05-2023
Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?
Öz: This study aims to evaluate the effectiveness of PCT (Platelet crit), NLR (Neutrophil-to-lymphocyte ratio), and PMI (Platelet Mass Index), which are among the complete blood count parameters, in predicting missed abortion (MA). The case-control study was conducted between January 1, 2020, and January 2022. A total of 926 pregnant women, including 474 MA and 452 normal patients, were included in the study. There were no significant differences between the patient and control groups in terms of age, gestational week, body mass index (BMI), gravida and parity, and thyroid functions (p>0.05). PMI, PCT, and NLR values were significantly higher in the MA group (p<0.05). While there was a strong positive relationship between PMI and PCT, there was a negative relationship between PMI and NLR (p<0.05). In the ROC anal ysis, PCT>0.24, NLR>2.99, and PMI>2430.9 were significantly associated with an increased risk of missed abortion (P<0.05). Logistic regression analysis rev ealed that a one- unit increase in PCT resulted in a statistically significant 3.41-fold increase in the risk of missed abortion, a one-unit increase in NLR resulted in a 2.56-fold increase, and a one-unit increase in PMI resulted in a 1.004-fold increase (p< 0.05). We think that PMI, NLR, and PCT values obtained from complete blood count parameters are important predictors of missed abortion.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 2012; 98: 1103–11.
- 2. Hu H, Yang H, Yin Z, Zhao L. Chromosome examination of missed abortion patients. Zhonghua Yi Xue Za Zhi 2015; 95:2837–40.
- 3. Askerov R. Embryoscopic diagnostics of endometrial defects in missed abortion after IVF. Gynecol Endocrinol 2016; 32 (suppl 2):62–3.
- 4. Dempsey MA, Flood K, Burke N, et al. Platelet function in patients with a history of unexplained recurrent miscarriage who subsequently miscarry again. Eur J Obstet Gynecol Reprod Biol 2015; 188:61-5.
- 5. Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009; 30:473–482
- 6. Jauniaux E, Poston L, Burton GJ. Placental related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution. Hum Reprod Update 2006; 12:747– 755.
- 7. Mihu D, Razvan C, Malutan A, Mihaela C. Evaluation of maternal systemic inflammatory response in preeclampsia. Taiwan J Obstet Gynecol 2015; 54:160–166.
- 8. Han L, Liu X, Li H, et al. Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for preeclampsia. PLoS One 2014; 9(12): e114488.
- 9. Akin MN, Kasap B, Yuvaci HU, Turhan N. Association between platelet indices and first trimester miscarriage. Blood Coagul Fibrinolysis 2016; 27:526-30.
- 10. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009; 133:628- 632
- 11. Pichler M, Hutterer GC, Stoeckigt C, et al. Validation of the pre-treatment neutrophil lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer 2013; 108:901-907.
- 12. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008; 102:653-657.
- 13. de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care 2010; 14:192
- 14. Gerday E, Baer VL, Lambert DK, Paul DA, Sola Visner MC, Pysher TJ, Christensen RD. Testing platelet mass versus platelet count to guide plateler transfusssions in the neonatal intensive care unit. Transfusion 2009; 49:2034-9.
- 15. Tang J, Gao X, Zhi M, et al. Plateletcrit: a sensitive biomarker for evaluating disease activity in Crohn’s disease with low hs-CRP. J Dig Dis 2015; 16: 118–124,
- 16. Wang J, Zhu QW, Cheng XY, et al. Assessment efficacy of neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in preeclampsia. J Reprod Immunol 2019; 132: 29–34
- 17. Calleja-Agius J, Jauniaux E, Pizzey AR, Muttukrishna S. Investigation of systemic inflammatory response in first trimester pregnancy failure. Hum Reprod 2012; 27:349–357
- 18. Hustin J. Histological study of the materno embryonic interface in spontaneous abortion. Placenta 1990; 11:477–486
- 19. Van Dreden P, Woodhams B, Rousseau A, Favier M, Favier R. Comparative evaluation of Tissue factor and Thrombomodulin activity changes during normal and idiopathic early and lte foetal loss: the cause of hypercoagulability? Thromb Res 2012; 129:787-92.
- 20. Calleja-Agius J, Jauniaux E, Pizzey AR, Muttukrishna S. Investigation of systemic inflammatory response in first trimester pregnancy failure. Hum Reprod 2012; 27:349- 57.
- 21. Serin S, Avcı F, Ercan O, Köstü B, Bakacak M, Kıranet H. Is neutrophil/lymphocyte ratio a useful marker to predict the severity of pre eclampsia? Pregnancy Hypertens 2016; 6:22-5.
- 22. Yiyenoğlu OB. Uğur MG, Özcan HÇ, Can G, Öztürk E, Balat Ö. Assessment of oxidative stress markers in recurrent pregnancy loss: a prospective study. Arch Gynecol Obstet 2014; 289:1337-40.
- 23. Bas FY, Tola EN, Sak S, Cankaya BA. The role of complete blood inflammation markers in the prediction of spontaneous abortion. Pak J Med Sci 2018; 34:1381-1385
- 24. Yakıştıran B, Tanacan A, Altınboğa O, Yücel A. Can derived neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and delta neutrophil index predict spontaneous abortion? Z Geburtshilfe Neonatol 2021; 225:418-422
- 25. Christoforaki V, Zafeiriou Z, Daskalakis G, Katasos T, Siristatidis C. First trimester neutrophil to lymphocyte ratio (NLR) and pregnancy outcome. J Obstet Gynaecol 2020; 40:59–64
- 26. Gorkem U, Kan O, Bostanci MO, Taskiran D, Inal HA. Kisspeptin and hematologic parameters as predictive biomarkers for first-trimester abortions. Medeni Med J 2021;36:98-105.
- 27. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003; 9:177-90.
- 28. Oglak SC, Aydin MF. Are neutrophil to lymphocyte ratio and platelet to lymphocyte ratio clinically useful for the predict ion of early pregnancy loss? Ginekol Pol 2020; 91:524-527
- 29. Aynıoglu O, Isık H, Sahbaz A, Harma MI, Isık M, Kokturk F. Can plateletcrit be a marker for recurrent pregnancy loss?. Clin Appl Thromb Hemost 2016; 22: 447-452.
- 30. Erdem ZS, Cayir Y, Kosan Z, Erdem HB. Is There any relation between recurrent miscarriage and complete blood count values? A case-control study. Konuralp Medical Journal 2020; 12:39-43.
- 31. Taşın C, Kadıoğlu N, Çiftçi RS, Coskun A, Aytan H. The role of platelet mass index in the prediction of preeclampsia. Journal of Experimental and Clinical Medicine 2022; 39:221- 225
- 32. Okur N, Büyüktiryaki M, Nurdan U, Şimşek GK, Canpolat FE, Oğuz ŞS. Could Platelet Mass Index Be Used As A Marker In Preterm Infants With Patent Ductus Arteriosus? The Journal of Gynecology - Obstetrics and Neonatology . 2017; Cilt 14, Sayı 1, 2017, 25 – 27
| APA | uckan K, Çeleğen İ, BAŞKIRAN Y, HANLIGİL E (2022). Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?. , 627 - 633. 10.5505/ejm.2022.45549 |
| Chicago | uckan Kazım,Çeleğen İzzet,BAŞKIRAN YUSUF,HANLIGİL Erhan Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?. (2022): 627 - 633. 10.5505/ejm.2022.45549 |
| MLA | uckan Kazım,Çeleğen İzzet,BAŞKIRAN YUSUF,HANLIGİL Erhan Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?. , 2022, ss.627 - 633. 10.5505/ejm.2022.45549 |
| AMA | uckan K,Çeleğen İ,BAŞKIRAN Y,HANLIGİL E Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?. . 2022; 627 - 633. 10.5505/ejm.2022.45549 |
| Vancouver | uckan K,Çeleğen İ,BAŞKIRAN Y,HANLIGİL E Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?. . 2022; 627 - 633. 10.5505/ejm.2022.45549 |
| IEEE | uckan K,Çeleğen İ,BAŞKIRAN Y,HANLIGİL E "Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?." , ss.627 - 633, 2022. 10.5505/ejm.2022.45549 |
| ISNAD | uckan, Kazım vd. "Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?". (2022), 627-633. https://doi.org/10.5505/ejm.2022.45549 |
| APA | uckan K, Çeleğen İ, BAŞKIRAN Y, HANLIGİL E (2022). Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?. Eastern Journal of Medicine, 27(4), 627 - 633. 10.5505/ejm.2022.45549 |
| Chicago | uckan Kazım,Çeleğen İzzet,BAŞKIRAN YUSUF,HANLIGİL Erhan Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?. Eastern Journal of Medicine 27, no.4 (2022): 627 - 633. 10.5505/ejm.2022.45549 |
| MLA | uckan Kazım,Çeleğen İzzet,BAŞKIRAN YUSUF,HANLIGİL Erhan Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?. Eastern Journal of Medicine, vol.27, no.4, 2022, ss.627 - 633. 10.5505/ejm.2022.45549 |
| AMA | uckan K,Çeleğen İ,BAŞKIRAN Y,HANLIGİL E Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?. Eastern Journal of Medicine. 2022; 27(4): 627 - 633. 10.5505/ejm.2022.45549 |
| Vancouver | uckan K,Çeleğen İ,BAŞKIRAN Y,HANLIGİL E Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?. Eastern Journal of Medicine. 2022; 27(4): 627 - 633. 10.5505/ejm.2022.45549 |
| IEEE | uckan K,Çeleğen İ,BAŞKIRAN Y,HANLIGİL E "Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?." Eastern Journal of Medicine, 27, ss.627 - 633, 2022. 10.5505/ejm.2022.45549 |
| ISNAD | uckan, Kazım vd. "Can Platelet Mass Index Be Used As A Prognostic Marker In The Diagnosis of Missed Abortion Patients?". Eastern Journal of Medicine 27/4 (2022), 627-633. https://doi.org/10.5505/ejm.2022.45549 |
